Regular inhaled beta agonist in asthma: effects on exacerbations and lung function

Taylor, D R; Sears, M R; Herbison, G P; Flannery, E M; Print, C G; Lake, D C; Yates, D M; Lucas, M K; Li, Q
February 1993
Thorax;Feb1993, Vol. 48 Issue 2, p134
Academic Journal
No abstract available.


Related Articles

  • PERSISTENT ASTHMA: LONG-ACTING β2-AGONISTS OR MORE STERIODS?  // Pulse;11/19/2005, Vol. 65 Issue 45, p40 

    The article focuses on the role of beta 2 agonists or more steroids in treating persistent asthma. The article determined the effects of both treatments on the: (1) incidence of asthma exacerbations; (2) pulmonary function; and (3) other measures of asthma control. Randomized controlled trials...

  • Do Children with Acute Asthma Benefit More from Anticholinergics and Beta2 Agonists than from Beta2 Agonists Alone? CLEARY-HAMMARSTEDT, CASEY; FLYNN, CHERYL A. // American Family Physician;2015 Special Issue, Vol. 91, p1 

    The article discusses a study on the therapeutic and adverse effects of adding inhaled anticholinergics to beta2 agonists in the treatment of acute pediatric asthma. Topics covered include group differences in lung function supporting combination therapy with anticholinergics and beta2 agonists,...

  • Chapter 15: Lessons learned from clinical trials of asthma. Sabin, Bradley R.; Avila, Pedro C.; Grammer, Leslie C.; Greenberger, Paul A. // Allergy & Asthma Proceedings;May/Jun2012 Supplement, Vol. 33, p51 

    The preponderance of clinical data suggest that inhaled corticosteroids (ICSs) are the preferred therapy for the long-term management of asthma, whereas oral or parental corticosteroids and short-acting beta2-adrenergic agonists remain the mainstay treatment of acute exacerbations. Allergen and...

  • Effect of Salmeterol Is independent of Previously Inhaled Salbutamol: A Clinical Controlled Study. Wilcke, J.T.R.; Iversen, E.T.; Kok-Jensen, A. // Lung;1998, Vol. 176 Issue 2, p133 

    Examines the bronchodilating effect of an inhaled long acting beta[sub 2]-agonist (salmeterol) after a high dose of an inhaled short acting beta[sub 2]-agonist (salbutamol) in asthma patients. Additive effect of combining salbutamol and salmeterol; Absence of an effect of inhaled salbutamol on...

  • Use of inhalers vs. nebulizers for children with asthma.  // American Family Physician;6/1/1995, Vol. 51 Issue 8, p1994 

    Reports on study comparing use of nebulizers and administration of beta agonists using metered-dose inhaler with a spacer device for treatment of children with asthma in February, 1995 issue of Archives of Pediatrics and Adolescent Medicine. Metered-dose inhaler with space device as an...

  • Chronic asthma. Cates, Christopher // BMJ: British Medical Journal (International Edition);10/27/2001, Vol. 323 Issue 7319, p976 

    Focuses on chronic asthma, defined as an exacerbation of underlying asthma requiring urgent or emergency treatment. Incidence; Aetiology and risk factors; Prognosis; Benefits and drawbacks of various treatments, including regular and as needed use of short acting inhaled beta 2 agonists.

  • Long-Acting β-Agonist Treatment in Patients with Persistent Asthma Already Receiving Inhaled Corticosteroids. Hancox, R.J.; Taylor, D.R. // BioDrugs;2001, Vol. 15 Issue 1, p11 

    International guidelines recommend that long-acting β-agonists should be considered in patients who are symptomatic despite moderate doses of inhaled corticosteroids. When combined with inhaled corticosteroids they improve asthma symptoms and lung function and reduce exacerbations. The...

  • Categorizing Asthma Severity:An Overview of National Guidelines. Colice, Gene L. // Clinical Medicine & Research;Aug2004, Vol. 2 Issue 3, p155 

    Asthma is an inflammatory disease of the airways associated with intermittent episodes of bronchospasm. Corticosteroids are the most effective anti-inflammatory class of medication currently available for the treatment of asthma. However, as higher doses of inhaled corticosteroids are used the...

  • Recent advance in inhaler medications for chronic obstructive pulmonary disease patients. Yeon-Mok Oh // Journal of the Korean Medical Association / Taehan Uisa Hyophoe ;Feb2014, Vol. 57 Issue 2, p155 

    Chronic obstructive pulmonary disease (COPD) is one of the highest ranking diseases with regard to prevalence and mortality in Korea and also worldwide. In the past decade, effective inhaler medications for COPD treatment have been developed or approved. These inhaler medications have been...

  • Management of Acute Asthma Exacerbations. POLLART, SUSAN M.; COMPTON, REBEKAH M.; ELWARD, KURTIS S. // American Family Physician;7/1/2011, Vol. 84 Issue 1, p40 

    Asthma exacerbations can be classified as mild, moderate, severe, or life threatening. Criteria for exacerbation severity are based on symptoms and physical examination parameters, as well as lung function and oxygen saturation. In patients with a peak expiratory low of 50 to 79 percent of their...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics